Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Biomaterials. 2009 Apr 23;30(22):3749–3756. doi: 10.1016/j.biomaterials.2009.03.050

Fig. 2.

Fig. 2

Photomicrographs demonstrating construct cellularity, GAG content, and collagen content for treatment groups in phase II. 10× original magnification. Treatment with 2% SDS for 1, 2, and 4 h decreased cellularity while preserving GAG and collagen content, while treatment for 6 and 8 h eliminated all nuclei, but also eliminated GAG and reduced collagen.